profit 427.9 354.5 73.4 20.7 Net gain (loss) on exchange rate 112.2 (28.3) 140.5 N.A. (>100) Gain on forward contracts 49.5 - 49.5 N.A. (>100) Other income 173.0 14.1 158.9 1,127.0 Profit before expenses
approval of the Cabinet, excluding currencies. “variable” means any exchange rate, interest rate, financial index, securities index or any other variables as specified in the notification of the SEC with the
profit 25.35 44.08 31.23 -12.85 -29.15 5.88 23.20 Profit (Loss) from exchange rate 0.12 1.19 0.54 -0.65 -54.62 0.42 350.00 Other Income 1.26 2.13 2.1 -0.03 -1.41 0.84 66.67 Gain from bargain purchase 33.64
) (100) (50) - 50 100 Q 1 2 0 1 9 Q 1 2 0 1 8 Statements of Cash Flows Dividend payment The company had the dividend payment policy stipulated that dividends shall be paid at the rate of not less than 40
the increase in total production cost, the company and subsidiary still could generate the Cash Margin which indicate that the Company was well in operation management. Net gain on foreign exchange rate
Gross profit 47.04 31.23 34.05 2.82 9.03 -12.99 -27.62 Profit (Loss) from exchange rate -0.21 0.54 3.24 2.70 500.00 3.45 -1,614.02 Other Income 1.46 2.1 2.02 -0.08 -3.81 0.56 38.36 Gain from bargain
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
International Hospital” to the Group. The finance costs decreased in the amount of Baht 5.9 million or 15.3% which in line with the management of interest rate of long-term debts. - Income tax for Q1/2018 in the
growth rate of 9.05%. Cost of hospital operations The cost of hospital operations amounted to Baht 134.79 million and Baht 146.47 million in the six-month period ended June 30, 2017 and the six-month